47.443275, 7.732506
PDF / print export
Bachem
Bubendorf, Switzerland
- Verified lead
- Anne-Kathrin Stoller
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Peptide API Manufacturing, Oligonucleotides, and GMP Supply
- Review cycle
- May 2026
- Full address
- Hauptstrasse 144, CH-4416 Bubendorf, Switzerland
- Site coordinates
- 47.443275, 7.732506
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Bachem executive committee page confirming Anne-Kathrin Stoller as CEO.
- Editorial note
- Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure.
Peptide API Manufacturing, Oligonucleotides, and GMP Supply
GMP peptide manufacturing, Global quality systems
Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated07 Jul 2026, 01:10
Company profile · Bubendorf, Switzerland
Bachem
Peptide API Manufacturing, Oligonucleotides, and GMP Supply · Global GMP manufacturing
Verified 14 Mar 2026 · 3 sources
API SynthesisCommercial
Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure.
Contact & location
- Website
- bachem.com
- Company page
- Lead
- Anne-Kathrin Stoller (verified ↗)
- Compliance
- GMP peptide manufacturing
- Last reviewed
- 14 Mar 2026 (4mo ago)
- Scale
- Global GMP manufacturing
- Capabilities
- Peptide APIs · Oligonucleotide Manufacturing · Commercial GMP Supply
- Founded
- 1971
- Headcount
- 1001-5000
Peptide API Manufacturing, Oligonucleotides, and GMP Supply
Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure.
Editorial note
Bachem strengthens the Swiss supply spine with a 2026 CEO transition already live on the official executive committee page.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Verification details
Clinical profileSTATUS: VERIFIED MARCH 2026
Anne-Kathrin Stoller
Chief Executive Officer
Full addressHauptstrasse 144, CH-4416 Bubendorf, Switzerland
Site coordinates47.443275, 7.732506
Review cycleMay 2026
Global GMP manufacturing
Bubendorf, Switzerland. Peptide API Manufacturing, Oligonucleotides, and GMP Supply. Review completed on 14 Mar 2026.
Swiss, EU, and global pharmaceutical manufacturing oversight
GMP peptide manufacturing, Global quality systems
Capabilities
Peptide APIs
Oligonucleotide Manufacturing
Commercial GMP Supply
Sources
The official sources used to verify this profile.
Infrastructure
API manufacturing suites
Analytical quality laboratories
Commercial GMP supply systems
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
Frequently asked questions
- Where is Bachem located?
- Bachem operates from Hauptstrasse 144, CH-4416 Bubendorf, Switzerland, Bubendorf, Switzerland.
- Who runs Bachem?
- Bachem is led by Anne-Kathrin Stoller, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Bachem hold?
- Bachem is documented under GMP peptide manufacturing.
- What does Bachem do?
- Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure. Core capabilities: Peptide APIs, Oligonucleotide Manufacturing, Commercial GMP Supply.
Editorial context
Related technical briefs
Briefs that name Bubendorf as a covered market or city.